All blog posts
Total 5 results for
Showing 5 out of 5 results
23 November 2022
SANCTION IMPOSED BY THE SPANISH COMPETITION AUTHORITY ON A PHARMA COMPANY FOR MISUSING LITIGATION STRATEGIES REGARDING PATENTS
11 October 2022
Update on the Teva Copaxone EU case. The EU Commission issues a Statement of Objections against Teva over alleged anti-competitive conduct consisting of misuse of divisional patents and a disparagement campaign against its closest competitor
27 June 2022
Overview of EU and South African regulatory and competition law in the Pharma sector
25 April 2022
Wide ranging reforms to UK competition and consumer protection regimes unveiled
21 April 2022
HSF team publishes update on antitrust developments in APAC
Showing 5 out of 5 results